Table 4.

Univariate analysis of cumulative incidence of TRM at one year




Cumulative incidence, %

95% CI for cumulative incidence, %

P

Hazard ratio

95% CI for hazard ratio
HLA-identical sibling    .001*   
   Wild type (55)   14   18-42   NA   1.0   
   R pos (9)   74   49-100   .000   7.9   2.6-24.0  
   D pos (6)   58   27-100   .022   4.9   1.3-18.9  
   R & D pos (8)   75   50-100   .004   6.4   1.8-23.0  
Matched unrelated donor    .04*   
   Wild type (61)   28   18-42   NA   1.0   
   R pos (13)   34   14-73   NS   1.1   0.4-3.3  
   D pos (9)   56   31-100   NS   2.4   0.9-6.5  
   R & D pos (4)
 
75
 
43-100
 
.01
 
4.2
 
1.4-12.5
 



Cumulative incidence, %

95% CI for cumulative incidence, %

P

Hazard ratio

95% CI for hazard ratio
HLA-identical sibling    .001*   
   Wild type (55)   14   18-42   NA   1.0   
   R pos (9)   74   49-100   .000   7.9   2.6-24.0  
   D pos (6)   58   27-100   .022   4.9   1.3-18.9  
   R & D pos (8)   75   50-100   .004   6.4   1.8-23.0  
Matched unrelated donor    .04*   
   Wild type (61)   28   18-42   NA   1.0   
   R pos (13)   34   14-73   NS   1.1   0.4-3.3  
   D pos (9)   56   31-100   NS   2.4   0.9-6.5  
   R & D pos (4)
 
75
 
43-100
 
.01
 
4.2
 
1.4-12.5
 

Univariate analysis of cumulative incidence of TRM at one year in patient/donor pairs with unmutated NOD2/CARD15 SNPs (wild type) versus pairs with either recipient (R pos) or donor mutations (D pos) or mutations in both (R & D pos). Separate analyses were performed for HLA-identical sibling transplantation and matched unrelated donor transplantations. Comparison between groups was performed using log-rank analysis.

CI indicates confidence interval; NA, not applicable; and NS, not significant.

*

Overall P value

or Create an Account

Close Modal
Close Modal